TALPHERA
Live / Applied — First extension granted (statement of use) (as of 09 Jul 2025)
What this means for you
Not registered yet, but its 30 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98246665
- Mark type
- Stylized text
- Filed
- 30 Oct 2023
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of renal diseases and hypotension; medical devices, namely, pre-filled syringes for the delivery of pharmaceutical preparations for the treatment of hypotension
- Class 010 — Medical apparatus: Medical devices for the delivery of anti-coagulants for the treatment of renal diseases;
Owner
- TALPHERA, INC., SAN MATEO, CA, US
- TALPHERA, INC., SAN MATEO, CA, US
- AcelRx Pharmaceuticals, Inc., San Mateo, CA, US
Prosecution history
- 07 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — SOU EXTENSION 1 GRANTED
- 09 Jul 2025 — SOU EXTENSION 1 FILED
- 09 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Dec 2024 — PUBLISHED FOR OPPOSITION
- 27 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 05 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 05 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN